Atra Group raised its current-year ordinary profit forecast and increased its full-year plan to ¥315 million. In its results announcement on 13 November, ordinary profit for the cumulative third quarter rose 2.7 times year on year to ¥258 million.
Atra Group announced its results after the market close on 13 November, reporting that consolidated ordinary profit for the cumulative third quarter (January-September) of the fiscal year ending December 2026 had surged to ¥258 million, 2.7 times the year-earlier level.
The full-year ordinary profit forecast was raised from ¥165 million to ¥315 million, with the projected growth rate expanding from 11.5% to 2.1 times. The second-half plan was also increased threefold, from the previous forecast of ¥74 million to ¥224 million, implying a turnaround to 89.8% growth.
In July-September, consolidated ordinary profit was 2.5 times the year-earlier level at ¥167 million, and the operating margin on sales improved sharply from 6.7% in the year-earlier period to 21.1%.
The company said that the A-COMS business remained steady and that sales of the AI device “Atra Gauge” and other products were strong, supported by growing demand for self-pay treatments. It also said it aims to strengthen its earnings base by expanding its healthcare operations.